在2013年至2023年期间,韩国的痴呆相关死亡统计数据
1Statistics Research Institute, Statistics Korea, Daejeon, Korea.
Ewha medical journal
|July 24, 2025
概括
韩国痴呆症死亡人数从2013年到2023年增加了66%,阿尔茨海默病是主要原因. 这一趋势凸显了改善痴呆症护理和预防策略的迫切需要.
科学领域:
- 老年学是指老年学的学科.
- 公共卫生 公共卫生
- 流行病学 流行病学
背景情况:
- 痴呆症在全球和韩国构成了重大和日益增长的公共卫生挑战.
- 了解与痴呆相关的死亡率趋势对于有效的公共卫生干预至关重要.
研究的目的:
- 分析2013年至2023年的韩国痴呆相关死亡统计数据.
- 确定痴呆症死亡率的趋势,包括原因和人口统计数据.
主要方法:
- 利用来自韩国统计局死亡原因统计数据的微数据.
- 使用国际疾病分类第十版代码提取和分析与痴呆相关的死亡.
- 检查了原始和年龄标准化死亡率的趋势,按性别,年龄,特定原因和死亡地点的死亡率.
主要成果:
- 与痴呆相关的死亡人数增加了66%,从2013年的8,688人增加到2023年的14,402人.
- 原始死亡率从每10万人的17.2上升至28.2,而年龄标准化死亡率略有下降.
- 阿尔茨海默病占痴呆症死亡人数的77.1%;女性和85岁以上的人群的死亡率更高.
结论:
- 痴呆的死亡率上升,特别是阿尔茨海默病的死亡率上升,意味着韩国的公共卫生问题非常重要.
- 这些发现需要加强预防,提高护理质量,以及针对痴呆症管理的有针对性的政策.
- 这一分析旨在为减少痴呆症的社会负担的策略提供信息.
相关概念视频
Dementia
166
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
The progression of dementia is generally gradual....
166
Alzheimer's Disease: Overview
669
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
669
Alzheimer's Disease: Treatment
262
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
262
Kubler Ross's Stages of Dying
346
Elisabeth Kübler-Ross significantly advanced psychology's understanding of the process of dying with her influential book, On Death and Dying (1969). She focused on studying terminally ill individuals and outlined five stages commonly experienced when coping with death: denial, anger, bargaining, depression, and acceptance.
In denial, individuals reject the reality of their condition, often thinking, "This isn't true; I feel fine," as a way to protect themselves from...
In denial, individuals reject the reality of their condition, often thinking, "This isn't true; I feel fine," as a way to protect themselves from...
346
Aging
185
Aging is a complex biological phenomenon influenced by various processes that affect cellular and systemic functions. Several prominent theories attempt to explain its mechanisms, highlighting cellular limitations, oxidative damage, and hormonal changes as central factors in aging.
Cellular Clock Theory
The cellular clock theory posits that the human lifespan is closely tied to the finite capacity of cells to divide, a phenomenon governed by telomeres, which are protective caps at the ends of...
Cellular Clock Theory
The cellular clock theory posits that the human lifespan is closely tied to the finite capacity of cells to divide, a phenomenon governed by telomeres, which are protective caps at the ends of...
185
Prevalence and Incidence
818
In statistical epidemiology and health sciences, two essential metrics—prevalence and incidence—are fundamental for understanding disease dynamics within a population. These measures enable public health officials, epidemiologists, and researchers to assess the burden of diseases, allocate resources effectively, and design impactful public health policies and interventions.
Prevalence indicates the proportion of individuals in a population who have a specific disease or health...
Prevalence indicates the proportion of individuals in a population who have a specific disease or health...
818


